Enrolling by invitationNCT06814353
Intraoperatively Observed Site of Origin and Growth Pattern of Medulloblastoma
Studying Medulloblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Christian Dorfer
- Intervention
- Intraoperative assessment of the site of origin and growth pattern(procedure)
- Enrollment
- 100 enrolled
- Eligibility
- All sexes
- Timeline
- 2024 – 2026
Study locations (4)
- Department of Neurosurgery, Medical University of Vienna, Vienna, Vienna, Austria
- Department of Neurosurgery, Charité Berlin, Berlin, Germany
- Section of Pediatric Neurosurgery, University Hospital of Tuebingen, Tübingen, Germany
- Department of Neurosurgery, Princess Maxima Centre for Pediatric Oncology, Utrecht, Netherlands
Collaborators
Medical University of Vienna · University Hospital Tuebingen · Utrecht University · Charite University, Berlin, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06814353 on ClinicalTrials.govOther trials for Medulloblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07085325CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal IrradiationSt. Jude Children's Research Hospital
- RECRUITINGPHASE2NCT06701812Digoxin Medulloblastoma StudyH. Lee Moffitt Cancer Center and Research Institute
- RECRUITINGNANCT06898684Medulloblastoma Online Video-based Exercise Pilot StudyAron Onerup
- RECRUITINGNCT07242963Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry StudyMohammad H. Abu Arja
- RECRUITINGEARLY PHASE1NCT06942039Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationC17 Council
- ACTIVE NOT RECRUITINGPHASE1NCT06514898Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With MedulloblastomaUniversity of Florida
- RECRUITINGNCT06779487Systemic Biomarkers to Predict Radiation-Induced Neurocognitive DeclineTata Memorial Centre
- RECRUITINGEARLY PHASE1NCT06959979Novel Molecular Targets and Innovative Therapeutic Perspective in MedulloblastomaFondazione Policlinico Universitario Agostino Gemelli IRCCS